These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 16906033

  • 1. The predictive value of soluble major histocompatibility complex class I chain-related molecule A (MICA) levels on heart allograft rejection.
    Suárez-Alvarez B, López-Vázquez A, Díaz-Molina B, Bernardo-Rodríguez MJ, Alvarez-López R, Pascual D, Astudillo A, Martínez-Borra J, Lambert JL, González S, López-Larrea C.
    Transplantation; 2006 Aug 15; 82(3):354-61. PubMed ID: 16906033
    [Abstract] [Full Text] [Related]

  • 2. Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas.
    Jinushi M, Takehara T, Tatsumi T, Hiramatsu N, Sakamori R, Yamaguchi S, Hayashi N.
    J Hepatol; 2005 Dec 15; 43(6):1013-20. PubMed ID: 16168521
    [Abstract] [Full Text] [Related]

  • 3. Post-transplant soluble MICA and MICA antibodies predict subsequent heart graft outcome.
    Suárez-Alvarez B, López-Vázquez A, Díaz-Peña R, Díaz-Molina B, Blanco-García RM, Alvarez-López MR, López-Larrea C.
    Transpl Immunol; 2006 Dec 15; 17(1):43-6. PubMed ID: 17157214
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Soluble NKG2D ligands in hepatic autoimmune diseases and in benign diseases involved in marker metabolism.
    Holdenrieder S, Eichhorn P, Beuers U, Samtleben W, Stieber P, Nagel D, Peterfi A, Steinle A, Salih HR.
    Anticancer Res; 2007 Dec 15; 27(4A):2041-5. PubMed ID: 17649819
    [Abstract] [Full Text] [Related]

  • 7. Proteolytic release of soluble UL16-binding protein 2 from tumor cells.
    Waldhauer I, Steinle A.
    Cancer Res; 2006 Mar 01; 66(5):2520-6. PubMed ID: 16510567
    [Abstract] [Full Text] [Related]

  • 8. [The roles of soluble MICA in immune escape of breast tumor].
    Ye YB, Zhou ZF, Chen Q, Li JY, Chen X, Huang WW.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Sep 01; 24(9):904-7. PubMed ID: 18782524
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA.
    Kloess S, Huenecke S, Piechulek D, Esser R, Koch J, Brehm C, Soerensen J, Gardlowski T, Brinkmann A, Bader P, Passweg J, Klingebiel T, Schwabe D, Koehl U.
    Eur J Immunol; 2010 Nov 01; 40(11):3255-67. PubMed ID: 21061445
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Anti-MICA antibodies are related to adverse outcome in heart transplant recipients.
    Kauke T, Kaczmarek I, Dick A, Schmoeckel M, Deutsch MA, Beiras-Fernandez A, Reichart B, Spannagl M.
    J Heart Lung Transplant; 2009 Apr 01; 28(4):305-11. PubMed ID: 19332255
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions.
    Arreygue-Garcia NA, Daneri-Navarro A, del Toro-Arreola A, Cid-Arregui A, Gonzalez-Ramella O, Jave-Suarez LF, Aguilar-Lemarroy A, Troyo-Sanroman R, Bravo-Cuellar A, Delgado-Rizo V, Garcia-Iglesias T, Hernandez-Flores G, Del Toro-Arreola S.
    BMC Cancer; 2008 Jan 21; 8():16. PubMed ID: 18208618
    [Abstract] [Full Text] [Related]

  • 16. Natural killer group 2 member D cell recruitment driven by major histocompatibility complex class I chain-related antigens A and B: a possible mechanism during acute intestinal allograft rejection in the mouse.
    Joshi M, Dindelegan G, Olausson M, Oltean M.
    Transplant Proc; 2010 Dec 21; 42(10):4467-9. PubMed ID: 21168719
    [Abstract] [Full Text] [Related]

  • 17. Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients.
    Rebmann V, Schütt P, Brandhorst D, Opalka B, Moritz T, Nowrousian MR, Grosse-Wilde H.
    Clin Immunol; 2007 Apr 21; 123(1):114-20. PubMed ID: 17218152
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.